【正文】
【參考文獻(xiàn)】 [1] 全國血壓抽樣調(diào)查協(xié)作組 .1991 年全國高血 壓抽樣調(diào)查工作總結(jié) [J].中華高血壓雜志, 1995, 3(S1):51 52. [2] 黃筱文 .老年性高血壓病診斷及治療進(jìn)展 [J].醫(yī)學(xué)綜述 , 2022, 11(7):632 634. [3] 劉力生,楊虎生,姚崇華,等 . 高血壓 [M]. 北京 :人民衛(wèi)生出版社, 2022:952 972. KKME專業(yè)醫(yī)學(xué)搜索引擎 [4] Hansson L, Zanchetti A, Carruthers SG, et al. Effective of intensive blood pressure lowing and low dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) rando mized trial[J]. Lancet,1998,351(9118):1755 1762. [5] UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular plication in type 2 diabetes : UKPDS 38[J]. BMJ, 1998,317(7160):703 713. [6] Adler AI,Stratton IM, Neil HA, et al .Association of systolic blood pressure with macrovascular and microvascular plication of type 2 diabetes (UKPDS 36): prospective observational study[J].BMJ,2022,321(7258):412 419. [7] Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed bination of perindopril and indapamide on macrovascular and microvascular outes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial[J]. Lancet,2022,370(9590):829 840. [8] Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotension converting enzyme inhibition pared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomized trial[J]. Lancet, 1999, 353(9153):611 616.